Medical Research News

RSS

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

Myriad Genetics, Inc. today presented several clinical studies on the Myriad myRisk- Hereditary Cancer test at the 2014 American Society of Clinical Oncology annual meeting in Chicago, Illinois.

2 Jun 2014

Parental presence during anesthesia induction improves quality of anesthesia for children

New research presented at this year's Euroanaesthesia meeting in Stockholm shows that having parents present during the induction of their child's anaesthesia improves the quality of that anaesthesia. The study is by Dr Alicia S-nchez, Department of Anaesthesiology, Hospital de Sagunto, Spain, and colleagues.

2 Jun 2014

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

New research presented at this year's Euroanaesthesia meeting in Stockholm shows that children exposed to indoor coal-burning stoves and/or second-hand tobacco smoke are much more likely to suffer postoperative complications and excessive pain after tonsillectomies.

2 Jun 2014

Volatile organic compounds in exhaled breath show presence and stage of lung cancer

Results of a University of Colorado Cancer Center study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) show that a test of organic compounds in exhaled breath can not only distinguish patients with lung cancer from patients with chronic obstructive pulmonary disease (COPD), but can also define the stage of any cancer present.

2 Jun 2014

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, and Quest Diagnostics, the world's leading provider of diagnostic information services, today announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors.

From Quest Diagnostics 2 Jun 2014

Particular genetic variation in humans linked with blond hair

A single-letter change in the genetic code is enough to generate blond hair in humans, in dramatic contrast to our dark-haired ancestors.

2 Jun 2014

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Pioneering 'tweezers' that use ultrasound beams to grip and manipulate tiny clusters of cells under electronic, push-button control could lead to life-changing medical advances, such as better cartilage implants that reduce the need for knee replacement operations.

31 May 2014

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with esophageal cancer are likely to respond or not respond to standard pre-surgical chemoradiation therapy.

31 May 2014

New software tool helps identify genetic mutations linked to increased risk for cancer

Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person's increased risk for developing common, complex diseases, such as cancer.

31 May 2014

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.

31 May 2014

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

Mount Sinai Heart will host its innovative and prestigious 17th Annual 2014 Live Symposium of Complex Coronary, Valvular, and Vascular Cases June 10-13 at The Mount Sinai Hospital.

31 May 2014

ASCO Expert Panel develops treatment guidelines for cancer-related fatigue

Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life.

31 May 2014

UTHealth’s professor receives highly competitive Fulbright-Nehru Scholarship Award

Anil Kulkarni, MSc, Ph.D., professor in the Department of Surgery at The University of Texas Health Science Center at Houston (UTHealth) Medical School, was awarded a highly competitive Fulbright-Nehru Scholarship Award for Academic and Professional Experience to travel to India this fall to teach immunonutrition and functional foods in the global health era.

31 May 2014

Forest publishes data from pivotal Phase III Study of Investigational FDC of nebivolol and valsartan

Forest Laboratories, Inc. (NYSE:FRX) today announced the publication of data from its pivotal Phase III Study of an Investigational Fixed-Dose Combination (FDC) of nebivolol and valsartan in the May 30, 2014 issue of The Lancet.

31 May 2014

Eisai announces results from Phase III SELECT trial of lenvatinib evaluating PFS in patients with RR-DTC

Eisai Inc. announced today results from the Phase III SELECT trial of investigational agent lenvatinib evaluating progression-free survival (PFS) in patients with progressive radioiodine-refractory differentiated thyroid cancer (RR-DTC).

31 May 2014

ASCO honors St. Jude researcher with 2014 Pediatric Oncology Award

The American Society of Clinical Oncology (ASCO) has named Leslie L. Robison, Ph.D., of St. Jude Children's Research Hospital the recipient of the 2014 Pediatric Oncology Award for his contributions to the field of childhood cancer survivorship research.

31 May 2014

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Boehringer Ingelheim today announced that new data will be presented from 7 abstracts for Gilotrif (afatinib) and investigational compounds, including nintedanib and BI 836845, from its oncology pipeline at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL, on May 30 – June 3, 2014.

31 May 2014

Significant advances in hypertension management prevent major cardiovascular events

Hypertension (raised blood pressure) treatment rates have almost doubled and control rates have trebled in England between 1994 and 2011, resulting in the saving of tens of thousands of lives each year, according to a new study published in a special themed issue of The Lancet.

31 May 2014

Researchers examine health and safety issues in sports

NFL teams shoulder most of the blame for players' injuries and sports journalists can shift football cultural norms toward valuing players who put their health first.

31 May 2014

Systolic, diastolic blood pressures may have different effects on different types of cardiovascular diseases

Raised systolic and diastolic blood pressures may have different effects on different types of cardiovascular diseases and at different ages, according to new research involving 1.25 million patients from primary care practices in England published in a special themed issue of The Lancet.

31 May 2014

Medical Research News

Myriad myRisk test solves overlap dilemma between hereditary cancer syndromes

Parental presence during anesthesia induction improves quality of anesthesia for children

Kids exposed to cooking or tobacco smoke more likely to suffer excessive pain after tonsillectomies

Volatile organic compounds in exhaled breath show presence and stage of lung cancer

Memorial Sloan Kettering Cancer Center, Quest Diagnostics partner for cancer tests

Particular genetic variation in humans linked with blond hair

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

New software tool helps identify genetic mutations linked to increased risk for cancer

HCV reactivation may not worsen survival outcomes for lymphoma patients with HIV

Mount Sinai Heart to host four-day symposium on Complex Coronary, Valvular, and Vascular Cases

ASCO Expert Panel develops treatment guidelines for cancer-related fatigue

UTHealth’s professor receives highly competitive Fulbright-Nehru Scholarship Award

Forest publishes data from pivotal Phase III Study of Investigational FDC of nebivolol and valsartan

Eisai announces results from Phase III SELECT trial of lenvatinib evaluating PFS in patients with RR-DTC

ASCO honors St. Jude researcher with 2014 Pediatric Oncology Award

New data on Gilotrif and investigational compounds to be presented at 50th ASCO annual meeting

Significant advances in hypertension management prevent major cardiovascular events

Researchers examine health and safety issues in sports

Systolic, diastolic blood pressures may have different effects on different types of cardiovascular diseases

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News